<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-042236</identifier>
<setSpec>0213-0599</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Use of atypical antipsychotics in Tourette´s syndrome</dc:title>
<dc:description xml:lang="en">Tourette's syndrome is a neuropsychiatric disorder characterized by chronic motor and vocal tics and a high comorbidity and associated symptoms. Usually, alpha-2 agonists (clonidine) or typical antipsychotics (haloperidol, pimozide) have been used with a good efficacy but they are poorly tolerated (adverse effects). We review here the existing evidences on efficacy and tolerance for the new antipsychotics (clozapine, risperidone, olanzapine, quetiapine, amisulpride, ziprasidoné) on this disorder</dc:description>
<dc:creator>Lucas Taracena, M. T de</dc:creator>
<dc:creator>Montañés Rada, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de GiIles de la Tourette (SGT) es un trastorno neuropsiquiátrico con tics motores y vocales crónicos y una elevada comorbilidad y síntomas secundarios. Se han venido usando agonistas alfa-2 (clonidina) o antipsicóticos clásicos (haloperidol, pimocida) con buena eficacia pero mala tolerancia (Efectos adversos). Revisamos la literatura existente sobre eficacia y tolerancia de los nuevos antipsicóticos (clozapina, risperidona, olanzapina, quetiapina, amisulpride, ziprasidona) en esta patología</dc:description>
<dc:source>An. psiquiatr;21(7): 331-339, dic. 2005.</dc:source>
<dc:identifier>ibc-042236</dc:identifier>
<dc:title xml:lang="es">El uso de los nuevos antipsicóticos atípicos en el síndrome de Gilles de la Tourette</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d8771^s22054</dc:subject>
<dc:subject>^d8771^s22053</dc:subject>
<dc:subject>^d32618^s22003</dc:subject>
<dc:subject>^d32618^s22020</dc:subject>
<dc:subject>^d32618^s22000</dc:subject>
<dc:subject>^d8771^s22012</dc:subject>
<dc:subject>^d14542^s22020</dc:subject>
<dc:subject>^d24387^s22016</dc:subject>
<dc:subject>^d24387^s22027</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d32618</dc:subject>
<dc:subject>^d24387^s22054</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d24387^s22053</dc:subject>
<dc:subject>^d14542</dc:subject>
<dc:subject>^d14542^s22000</dc:subject>
<dc:subject>^d14542^s28898</dc:subject>
<dc:subject>^d8771^s22027</dc:subject>
<dc:type>article</dc:type>
<dc:date>200512</dc:date>
</metadata>
</record>
</ibecs-document>
